Clinical Trial Management System Market – All You Need to Know About Emerging Trends
Research Methodologies Followed for This Study:
Secondary Research:
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information...
Healthcare CRM Market: Trends and Opportunities
The benefits of CRM
software and a growing focus on patient engagement are the major factors
driving the growth of the healthcare CRM market.
The report Healthcare CRM Market is projected to reach USD 17.4 billion by 2023 from USD 8.8
billion in 2018, at a CAGR of 14.6% during the forecast period.
Ask
for PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=88873203
Scope...
Healthcare Interoperability Solutions Market worth $5.7 billion by 2026 – Exclusive Report by MarketsandMarkets™
The Growth in Healthcare
Interoperability Solutions Market is driven by the
growing need to curtail healthcare costs, government initiatives to enhance
patient care & safety, government funding for healthcare interoperability,
and the rapid adoption of EHR & other healthcare IT solutions. However, the
lack of true interoperability solutions, lack of standards, and the use of
outdated legacy...
COVID-19 Impact And Market Dynamics Analysis For Urinalysis Market
COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. The COVID-19 pandemic negatively affected the overall sales of most of the companies Lockdowns resulting from the COVID-19 pandemic caused...
The Growth Of ELISpot Assay Market
Growth in this market is driven by the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers. On the other hand, the availability of alternative detection technologies is expected to limit market growth during the forecast period.
By...
Revenue Cycle Management Market worth $67.8 billion by 2026 – Exclusive Report by MarketsandMarkets™
“Revenue Cycle Management/RCM Market by
Product & Services (Eligibility Verification, Clinical Coding, CDI, Claims
Processing, Denial Management, Outsourcing Services, Cloud), End User(Payers,
Hospitals, Outpatient), Covid-19 Impact – Global Forecast to 2026″, published
by MarketsandMarkets™, the global RCM Market is projected to reach USD 67.8 billion by...
COVID-19 Impact on Global Hospital Acquired Infection Control Market
The pandemic has disrupted healthcare systems worldwide, with hospitals being overwhelmed due to the increasing influx of patients. Temporary hospitals are also being set up to deal with the growing number of cases. Hence, the spread of COVID-19 has spurred a surge in demand for HAI services due to the growing cases of HAIs in hospital settings.
With the current COVID-19 pandemic wreaking havoc...
The Future of Bioanalytical Testing Services Market
[208 Pages Report] The global bioanalytical testing services market is projected to reach USD 6.0 billion by 2027 from an estimated USD 2.9 billion in 2022, at a CAGR of 15.6% during the forecast period. In 2021, North America accounted for the largest share of the market, followed by Europe.
The major factors influencing the growth of the North American market include the well-established...
Growth In The Demand For Blood Culture Tests Market
Globally, bloodstream infections affect about 30 million people leading to 6 million deaths, with 3 million newborns and 1.2 million children suffering from sepsis annually. In Eastern African countries, the proportion of patients with bloodstream infections is reported to range from 11% to 28%. In Ghana, bloodstream infection rates are estimated to be in the range of 9.3% to 11.2% (Source: Journal...
Blood Collection Devices Market – Growing Emergence of Liquid Biopsy Tests
The rising prevalence of infectious diseases such as hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency virus (HIV), malaria, syphilis, and brucellosis are a major factor driving the demand for effective blood collection (due to the risk of disease transmission during blood transfusion). According to the WHO (July 2021), there were an estimated 37.7 million [30.2–45.1 million] people living...